StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) income statement

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.23−0.01 (-4.53%)

Close on Oct 19, 2026Market cap $1.04MP/E –Yield –

See a number that looks wrong?